Blog

Nirmala Bhoo Pathy: The London Global Cancer Week to improve cancer outcomes globally

Nirmala Bhoo Pathy/tatlerasia.com

Sep 13, 2024, 18:50

Nirmala Bhoo Pathy: The London Global Cancer Week to improve cancer outcomes globally

Nirmala Bhoo Pathy shared a post by London Global Cancer Week on LinkedIn, adding:

“The London Global Cancer Week is a diverse series of 30-40 individual meetings presented by a range of hosts committed to improving cancer outcomes globally.

As an avid follower of the event, I have been tuning in virtually for several years. We also ‘went on air’ when our Lancet Commission on Women, Power and Cancer was in the making.

And now, I am beyond honored to be invited to speak in the main physical session of LGCW, titled Cancer Health Disparities: Understanding the Inequality Conundrum, chaired by the amazing Dr Olubukola Ayodele.

I will be discussing how local data can be utilized to gain insights into cancer disparities, spotlighting groups that are likely to be left behind if health systems do not take timely action. Come join us.”

Quoting London Global Cancer Week:

“London Global Cancer Week 2024 is set to bring together experts from November 11-15, focusing on advancing global cancer care and research.

Join us in London or virtually to hear from leading voices in the field. Review the schedule today and plan your participation.”

Nirmala Bhoo Pathy: The London Global Cancer Week to improve cancer outcomes globally

Source: Nirmala Bhoo Pathy/LinkedIn and London Global Cancer Week/LinkedIn

Nirmala Bhoo-Pathy is a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, University Malaya, and practices as a public health physician at the University Malaya Medical Centre, Malaysia. She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014. Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy.

Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN). She currently serves in two Lancet Commissions: the Lancet Commission on Women and Cancer and the Lancet Commission on Cancer and Health Systems. As the founder and scientific lead of a solution-oriented research group ‘Well with Cancer in Malaysia (WeCan@MY) https://spm.um.edu.my/wecan@my/ in the Department of Social and Preventive Medicine, Nirmala Bhoo-Pathy currently oversees a wide range of studies on cancer care, cancer control and cancer policy, locally and globally.